The ATP5F1E gene helps build part of the cell’s energy making machinery in mitochondria, where nutrients are turned into ATP, the fuel your cells use every day. If this gene does not work properly, cells may struggle to make enough energy, which can especially affect the brain, muscles, and other tissues with high energy needs. A severe variant in the ATP5F1E gene can cause a rare mitochondrial condition linked to low muscle tone, feeding problems, developmental delay, and high lactic acid levels in the blood.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Others mostly regulate when certain processes happen, where they take place, and how active they are. As a group, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
ATP5F1EGene function
What if the gene works
The ATP5F1E gene helps mitochondria, your cells' energy makers, produce ATP, the main energy source cells use. This supports organs with high energy needs, especially the brain and muscles.
Risk
What if the gene does not work
Variants in the ATP5F1E gene can cause a mitochondrial condition with poor energy production, often leading to lactic acidosis, developmental delay, and muscle or brain involvement. Milder and more severe variants can influence when symptoms begin and overall severity.
Treatment
What does that mean for your treatment
No ATP5F1E-specific treatment or drug selection strategy is currently established. ATP synthase pathways are being studied in mitochondrial disease research, but no ATP5F1E-targeted therapy is in current clinical use.
Conditions associated with ATP5F1E
Gene function
What if the gene works
Inside your mitochondria, the ATP5F1E gene helps your cells make ATP, the main form of usable energy. Its protein is one small but important part of the machine that carries out this step. This steady energy supply supports everyday tasks across the body, especially in tissues that use a lot of energy.
The ATP5F1E gene provides instructions for one piece of ATP synthase, the mitochondrial machine that makes ATP. ATP is the cell’s main usable energy source for work such as muscle movement, nerve signaling, and heartbeat.
Its protein helps ATP synthase link energy moving across the inner mitochondrial membrane to ATP production. This is a key part of how the ATP5F1E gene helps mitochondria make energy for everyday cell activity.
This protein supports the shape and steady assembly of the ATP synthase complex. A well built energy making machine helps mitochondria supply ATP in a consistent, controlled way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and form part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATP5F1E gene can alter the shape or amount of a small part of the cell’s energy-making machinery, so the full complex may assemble poorly or work less efficiently. In plain terms, this explains how ATP5F1E gene variants affect cells: they can reduce ATP production, the main energy supply used by tissues. Milder variants may leave some activity, while more disruptive variants can cause a larger drop in function and are linked to earlier or more marked mitochondrial disease.
How variants are linked to conditions
When doctors discuss ATP5F1E gene variants linked to conditions, the best-established connection is to a rare inherited condition called combined oxidative phosphorylation deficiency 12. This condition usually begins in infancy and may include low muscle tone, feeding or breathing difficulties, developmental delay, and high lactic acid levels in the blood. Because this is a single-gene condition, finding a pathogenic variant in the ATP5F1E gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some cases, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the ATP5F1E gene. For families with a known ATP5F1E change, overall risk is mainly shaped by whether the gene change was inherited, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of ATP5F1E variants
ATP5F1E-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one ATP5F1E gene variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of resulting in a child without the familial variants. In practical terms, ATP5F1E gene inheritance often appears unexpectedly in a family because carrier parents usually do not have symptoms themselves.
What does my ATP5F1E result mean for my family?
Changes in the ATP5F1E gene linked to disease are passed down in families in a recessive way, so close relatives may also be carriers even if they are healthy. Brothers and sisters of an affected child may also be affected or be carriers. For family members, the main question is often whether they carry the same gene change and could pass it on to children.
Genetic information
Genetic testing
How you find out about variants
To find variants in the ATP5F1E gene, genetic testing for ATP5F1E variants usually uses a blood or saliva sample. A laboratory reads the DNA sequence and looks for changes linked to mitochondrial disease. Results may identify a variant linked to disease, a benign change, or an uncertain finding.
When should I consider getting a genetic test?
Genetic testing for the ATP5F1E gene may be worth considering when a baby or child has signs of a rare condition that affects how cells make energy, such as poor feeding, low muscle tone, developmental delay, or high lactic acid levels, or when an ATP5F1E variant is already known in the family.
A genetic result is only one part of your health story
A genetic result can give useful insight, but how much it explains depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially ones shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or uses a drug, so the same treatment may work better for one person than for another. This is a common part of human biology and can influence both how well a medicine helps and how sensitive someone may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape the way a person responds to medication. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the ATP5F1E gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about side effects, treatment response, or your overall health are best discussed with your doctor.
History
Research on mitochondrial ATP synthase in the second half of the 20th century gradually led scientists to identify its smaller protein parts, including the one encoded by the ATP5F1E gene. From these first observations, research expanded steadily as biochemistry and early DNA sequencing made it possible to map the gene more precisely in humans. Later studies connected rare ATP5F1E variants with inherited mitochondrial disease, helping clarify why some families developed symptoms linked to reduced cellular energy production. Scientific classifications changed as researchers learned more about the gene. Today, ATP5F1E is recognized as part of the broader history of mitochondrial medicine and the effort to understand rare energy related genetic conditions.